Molecular Diagnostics
Quick, Affordable Finger-Prick Test Diagnoses Common STI in Five Minutes
Researchers have developed an affordable and fast finger-prick test for diagnosing trichomonas vaginalis, a sexually transmitted infection that is highly prevalent but often overlooked The test can deliver results in just five minutes and can be produced for under USD 20. More...28 Mar 2023
Automated Sample-to-Result PCR Test Enables Rapid Genotyping for Antiplatelet Therapy
The CYP2C19 enzyme plays a critical role in metabolizing approximately 10% of current clinically used medications. The Genomadix Cube CYP2C19 System (Cube CYP2C19 test) is an automated sample-to-result PCR test that can be used by clinicians to determine the therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. More...27 Mar 2023
Handheld Molecular POCT System Enables Rapid Onsite Testing at Hospital ERs and Clinics
The deployment of a handheld molecular POCT system and nucleic acid test cards in outpatient departments, inpatient departments and emergency rooms can provide access to results 3 to 5 hours ahead of traditional PCR, allowing hospitals to better manage patient flow and length of stay. More...27 Mar 2023
Next Gen Technology Enables Robust, Straightforward and Flexible Molecular Diagnostics in Any Environment
A next-generation ‘Anywhere, anytime, by anyone’ molecular detection technology aims to shift the detection and monitoring of viral infections to point-of-care and beyond clinical settings. The technology, which allows for rapid and precise measurement and quantification of viral RNA, DNA, antigens, or antibodies, can be used by anyone, anywhere, at any time. More...24 Mar 2023
Portable PCR Molecular Analyzer Delivers Time-Critical Results in Near-Patient Setting
Conventional laboratory-based tests may require several days or weeks to generate results. Now, a fast, accurate, and portable DNA analyzer goes from sample to result in approximately an hour, making results more accessible. More...24 Mar 2023
First-of-Its-Kind Test Helps Determine Future Risk of Esophageal Cancer
Barrett's esophagus is the sole precursor known and is a significant risk factor for the development of esophageal cancer. It is crucial to identify patients with Barrett's esophagus who will go on to develop high-grade dysplasia or esophageal cancer in the future. Now, a new test can meet this important unmet medical need by enabling accurate prognosis and detection data for individuals who may be susceptible to esophageal cancer. More...23 Mar 2023
Handheld Immunoanalyzer Performs Laboratory Tests near Patient without Sacrificing Sensitivity and Precision
A handheld portable immunoanalyzer with the sensitivity and precision of centralized laboratory equipment is currently being developed in a form factor suitable for low-cost, point-of-care testing anywhere in the world. More...22 Mar 2023
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
8-Channel Pipette
SAPPHIRE 20–300 µL
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
In Other News
Point-of-Care MDx System Enables Simple, Fast and Accurate Diagnosis in Near Patient Setting
Near-Patient Molecular Test Outperforms Other Rapid Measures for Sepsis Diagnosis
Biomarker-Based Approach Could Identify Early Risk of Pancreatic Cancer
Simple, Inexpensive Genetic Test Can Identify MS Patients at Risk of Fatal Brain Infection
Unique Dye-Based Tests to Revolutionize Early-Detection Pancreatic Cancer Diagnostics
Novel Lymph Liquid Biopsy Could Transform Approach for Identifying Cancer Recurrence Risk
First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis Uses Only One Swab
Novel Biosensor to Detect DNA Damage in Real Time Could Revolutionize Cancer Treatment
High-Sensitivity Troponin I Could Predict Preeclampsia in High-Risk Women
‘Glow-In-The-Dark’ Proteins to Help Diagnose Viral Diseases More Quickly and Easily
Novel Test to Ensure Essential Treatment for Newborns with Serious Genetic Disease
Affordable Blood-Based Test Provides Early Detection of Colorectal Cancer
Novel Non-Sputum Based Technology Quickly and Easily Detects Active TB
Rapid PCR Diagnostic Test for STIs Provides Accurate Results in Less than 30 Minutes at POC
Urine-Based Molecular Test Detects Bladder Cancer Quickly and Accurately
Urine Gene Test Could Detect Bladder Cancer Years Before Symptoms Arise
Simple Blood Test Could Make It Easier to Diagnose Epilepsy
New AI Blood Test Could Become Game Changer for Bowel Cancer Diagnosis
Blood Test Detects Alzheimer's with 97% Accuracy 10 Years Before Symptoms Emerge
Blood Test Identifies Acute Myeloid Leukemia Patients Having Higher Relapse Risk
First Commercially Available Lab-Based Blood Test to Help Evaluate Concussion
ApoB Protein Testing More Accurately Predicts Heart Disease Risk than Testing for Cholesterol Alone
Awareness Announces Major Upgrades to Stat Fax 4700 ELISA Strip Reader
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.